Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tinker, A.V.
460  Ergebnisse:
Personensuche X
?
1

Population exposure-safety and exposure-efficacy analyses f..:

Konecny, G.E. ; Oza, A.M. ; Tinker, A.V....
Gynecologic Oncology.  159 (2020)  - p. 92-93 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Safety and efficacy of the anti–PD-1 monoclonal antibody do..:

Oaknin, A. ; Tinker, A.V. ; Gilbert, L....
Gynecologic Oncology.  159 (2020)  - p. 6 , 2020
Link: https://doi.org/10.1016/..
 
?
3

A Canadian cancer trials group phase IB study of durvalumab..:

Nehra, J. ; Bradbury, P. A. ; Ellis, P. M....
Investigational New Drugs.  38 (2020)  5 - p. 1442-1447 , 2020
Link: https://doi.org/10.1007/..
 
?
4

Avelumab alone or in combination with pegylated liposomal d..:

Pujade-Lauraine, E. ; Fujiwara, K. ; Ledermann, J.A....
Gynecologic Oncology.  154 (2019)  - p. 21-22 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Outcomes of whole genome and transcriptome sequencing (WGTS..:

Liu, S.L. ; Nelson, J.M.T. ; Taylor, G.A....
Gynecologic Oncology.  154 (2019)  - p. 232-233 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Costs and benefits of tumor testing formutations in high-gr..:

Kwon, J.S. ; Tinker, A.V. ; Karsan, A...
Gynecologic Oncology.  154 (2019)  - p. 177 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Costs and benefits of tumor testing formutations in high-gr..:

Kwon, J.S. ; Tinker, A.V. ; Karsan, A...
Gynecologic Oncology.  154 (2019)  - p. 5 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Time without symptoms or toxicity in patients with recurren..:

Matulonis, U.A. ; Walder, L. ; Nøttrup, T.J....
Gynecologic Oncology.  154 (2019)  - p. 2 , 2019
Link: https://doi.org/10.1016/..
 
?
9

PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRA..:

Mirza, M.R. ; Walder, L. ; Monk, B.J....
Value in Health.  21 (2018)  - p. S16 , 2018
Link: https://doi.org/10.1016/..
 
?
10

BRCA1 and RAD51C promoter hypermethylation confer sensitivi..:

Swisher, E.M. ; Harrell, M.I. ; Lin, K....
Gynecologic Oncology.  145 (2017)  - p. 5 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Rucaparib in patients with relapsed, primary platinum-sensi..:

Konecny, G.E. ; Oza, A.M. ; Tinker, A.V....
Gynecologic Oncology.  145 (2017)  - p. 2 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Integrated efficacy and safety analysis of the poly(ADP-rib..:

Oaknin, A. ; Oza, A. ; Tinker, A.V....
European Journal of Cancer.  72 (2017)  - p. S95 , 2017
Link: https://doi.org/10.1016/..
 
?
13

18F FDG positron-emission tomography findings of gliomatosi..:

Lavoie, J.-M. ; Lacroix-Poisson, F. ; Hoang, L.N....
Gynecologic Oncology Reports.  20 (2017)  - p. 105-107 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Secondary mutations in RAD51C and RAD51D are associated wit..:

Lin, K. ; Tinker, A.V. ; Kondrashova, O....
European Journal of Cancer.  69 (2016)  - p. S13 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Dose-dense Paclitaxel in Advanced Ovarian Cancer:

Kumar, A. ; Hoskins, P.J. ; Tinker, A.V.
Clinical Oncology.  27 (2015)  1 - p. 40-47 , 2015
Link: https://doi.org/10.1016/..
 
1-15